The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

Six subjects with a history of atopic dermatitis (AD ... None of the subjects had active dermatitis on the skin of the back. Consistent areas of skin were sampled for each material and each ...

Translational research and innovative therapies have greatly transformed the understanding of the most relevant pillars of atopic dermatitis (AD) pathogenesis: abnormal immune response, pruritus, ...

Sometimes symptoms can become so severe that the skin cracks and oozes. Symptoms may wax and wane over time. If severe, the lesions may bleed and cause scarring. Painful symptoms can also interfere ...

Explore innovative nutritional and microbial strategies for effectively treating acne, alopecia, and atopic dermatitis.

Dermavant Sciences has shared positive long-term results for its plaque psoriasis-approved Vtama (tapinarof) cream in adults ...

Clothing, especially rough fabrics like wool, can cause problems if you have a skin condition called atopic dermatitis. It’s the most common form of eczema. The AAD estimates that 10% to 20% of ...

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...